Fair Money & Economic Opportunity

The provided articles are placeholders and explicitly state that they contain no data relevant to Puma Biotechnology Inc or the 'Fair Money & Economic Opportunity' value.

As such, there is no evidence to score any of the KPIs, which primarily pertain to financial services and lending practices. Puma Biotechnology Inc is described as a biopharmaceutical company, and the articles do not provide any information about its involvement in financial services.

Fair Pay & Worker Respect

No relevant data or specific metrics regarding Fair Pay & Worker Respect for PBYI.US were found in the provided articles.

The articles explicitly state that they do not contain information on living wages, CEO pay ratios, collective bargaining, safety incidents, pay equity, worker engagement, turnover, labor violations, insecure contracts, or health insurance coverage for the company.

Honest & Fair Business

Puma Biotechnology has a formal whistleblower protection policy, including an independent ethics helpline that offers anonymity.

However, there is no explicit evidence regarding independent investigation processes, training frequency, or program effectiveness. The company's Code of Business Conduct and Ethics explicitly addresses the Foreign Corrupt Practices Act (FCPA), prohibiting bribery and kickbacks, and requires prior approval for facilitation payments. Its Compliance Program incorporates the seven elements recommended by the U.S. Department of Health and Human Services Office of Inspector General (OIG) and includes policies consistent with the PhRMA Code on Interactions with Health Care Professionals. However, the evidence does not specify the frequency or effectiveness metrics of anti-corruption training.

Planet-Friendly Business

Puma Biotechnology, Inc. states a commitment to providing a safe and healthy working environment and avoiding adverse environmental impact and injury to communities.

The company requires employees and directors to comply with all applicable environmental, health, and safety laws, regulations, and company standards. Employees are also encouraged to conserve resources and reduce waste and emissions through recycling and other energy conservation measures, and to report any known or suspected environmental violations. However, the provided articles do not contain any specific, quantifiable data points or outcomes regarding environmental performance, such as greenhouse gas emissions, renewable energy usage, waste diversion rates, water consumption, or the existence of science-based targets or green building certifications.

Respect for Cultures & Communities

No data relevant to the 'Respect for Cultures & Communities' value was found in the provided article.

The article focuses on Puma Biotechnology's financial results, clinical trials, and FDA-approved treatments for cancer, without mentioning community engagement, cultural sensitivity, or related initiatives.

Safe & Smart Tech

Puma Biotechnology experienced a data breach between April 22, 2022, and June 19, 2022, affecting approximately 1,933 individuals.

The compromised data included full names, Social Security numbers, financial account information, and health insurance information. The company discovered suspicious activity on June 19, 2022, but did not send notification letters to victims until May 17, 2023. Following the breach, Puma launched an investigation with third-party specialists, reported the incident to federal law enforcement, and offered one year of free credit monitoring and identity theft restoration services. The company states it complies with applicable federal and state laws, including GDPR and CCPA, and its privacy policy outlines user rights such as access, correction, and erasure. The company also states it collects data as reasonably necessary and responds to Global Privacy Control (GPC) signals from California residents. Employee cybersecurity awareness training is mentioned, but no details on its effectiveness are provided.